Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation
Immune Network · 2026 · 26 (1)
DOI: 10.4110/in.2026.26.e11 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immune Network, 2026. Verfasst von Hyo-Jung Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Convergence Medicine, Korea University College of Medicine, Seoul 02708, Korea. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Convergence Medicine, Korea University College of Medicine, Seoul 02708, Korea.
- BK21 Graduate Program, Department of Biomedical Science, Korea University College of Medicine, Seoul 02841, Korea.
- Department of Cell Biology, Daegu Catholic University School of Medicine, Daegu 42472, Korea.
ORCID-Profile: Hyo-Jung Lee, Eunho Cho, Kwon-Ho Song, Tae Woo Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Lee, H. J., Cho, E., Song, K. H., & Kim, T. W. (2026). Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation. Immune Network, 26(1). https://doi.org/10.4110/in.2026.26.e11
Vancouver
Lee HJ, Cho E, Song KH, Kim TW. Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation. Immune Network. 2026;26(1). doi:10.4110/in.2026.26.e11
BibTeX
@article{Lee2026,
author = {Lee, Hyo-Jung and Cho, Eunho and Song, Kwon-Ho and Kim, Tae Woo},
title = {Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation},
journal = {Immune Network},
year = {2026},
volume = {26},
number = {1},
doi = {10.4110/in.2026.26.e11}
}
EUVIMED